Witold Kowal

Witold Kowal

Auto-generated profile, based on publicly available information

Witold Kowal


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2026 in Acta Poloniae Pharmaceutica - Drug Research
Verified
Journal Article
Open access
MKMarta Kończak
Marta Kończak
WKWitold Kowal
Witold Kowal
PRPiotr Ratajczak
Piotr Ratajczak
APAnna Paczkowska
Anna Paczkowska
DKDorota Kopciuch
Dorota Kopciuch
TZTomasz Zaprutko
Tomasz Zaprutko
Advertising of medicinal products during children’s television programming is strictly regulated in Poland (Article 53, paragraph 3 of the Pharmaceutical Law) and other European Union member states, where targeting pharmaceutical messages at minors is prohibited. This study aimed to verify the presence, frequency, and duration of pharmaceutical advertisements in children's programming, comparing Poland with Spain, France, Italy, Germany, Denmark, and Sweden. The material consisted of publicly available broadcasts from selected children's channels: in Poland (July-August 2024), in other countries (November 2024), and in all locations again (December 2024). During each of these periods, observers analysed selected, randomly chosen 60-minute broadcast segments aired between 7:00 AM and 8:00 PM, recording total advertising time and pharmaceutical spot duration. Advertised products were classified into therapeutic groups (e.g., analgesics, vitamins, cold remedies). Pharmaceutical advertising directed at children was found only in Poland and Spain. In Poland, such ads represented 22.3% of total advertising time in summer 2024 (2 min 11 s of 9 min 46 s) and 14.6% in December 2024 (38 s of 4 min 22 s). In Spain, a single instance occurred in November 2024, representing 13.7% (20s of 2 min 25s) of total advertising time. No pharmaceutical advertisements targeting children were detected in France, Italy, Germany, Denmark, or Sweden. Pharmaceutical advertising during children’s programming persists in Poland despite legal restrictions, suggesting insufficient enforcement. In contrast, the absence of such content in other EU countries indicates effective regulation and oversight that protect minors from exposure to pharmaceutical marketing.